Literature DB >> 12583797

Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone.

Matthew S Benz1, Timothy G Murray, Sander R Dubovy, Randy S Katz, Charles W G Eifrig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12583797     DOI： 10.1001/archopht.121.2.271

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  23 in total

Review 1.  Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity).

Authors:  Tatiana I Kuznetcova; Alain Sauty; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2012-06-02       Impact factor: 2.031

2.  Retinal complications of intravitreal injections of triamcinolone acetonide.

Authors:  Jost B Jonas; Ingrid Kreissig; Robert F Degenring
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-16       Impact factor: 3.117

3.  Morphallaxia-like ocular histology after intravitreal triamcinolone acetonide.

Authors:  J B Jonas; U Bleyl
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

4.  Accurate placement of corticosteroids into the sub-Tenon's space provides good drug penetration into the eye.

Authors:  A A Okada; T Wakabayashi
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

5.  Periocular corticosteroid therapy: comments.

Authors:  V Vedantham
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

Review 6.  [Ocular side effects and complications of intravitreal triamcinolone acetonide injection].

Authors:  G B Jaissle; P Szurman; K U Bartz-Schmidt
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

7.  Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.

Authors:  J B Jonas; I Kreissig; R F Degenring
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

8.  Trans-Tenon's retrobulbar injection of triamcinolone acetonide for diffuse diabetic macular edema.

Authors:  Mitsumasa Wada; Nahoko Ogata; Keizo Minamino; Masataka Koriyama; Akiko Higuchi; Miyo Matsumura
Journal:  Jpn J Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 2.447

9.  Intravitreal triamcinolone acetonide: a "real world" analysis of visual acuity, pressure and outcomes.

Authors:  Victor Manuel Villegas; Aaron Samuel Gold; Andrea Wildner; Azeema Latiff; Timothy Garrett Murray
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

10.  Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors.

Authors:  Ziad F Bashshur; Abdallah M Terro; Christelle P El Haibi; Akaber M Halawi; Alexandre Schakal; Baha' N Noureddin
Journal:  Clin Ophthalmol       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.